Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation
Authors:
Delia Dima, Adrian P. Trifa, Mariana Pațiu, Cristian S. Vesa, Ioana C. Frinc, Ljubomir Petrov, Andrei Cucuianu